Articles tagged with Randomization
This randomized clinical trial suggests that transcutaneous auricular vagus nerve stimulation is a safe and effective treatment option for chronic insomnia. Future multicenter trials are needed to validate its effectiveness across different populations.
Women with low-risk ductal carcinoma in situ reported similar experiences undergoing active monitoring versus guideline-concordant care. The study found that both approaches had comparable lived experiences during the 2-year follow-up period.
A randomized study found that active monitoring for low-risk ductal carcinoma in situ did not increase invasive cancer risk compared to guideline-concordant care. Women on active monitoring had comparable rates of disease recurrence and survival.
A randomized clinical study found that an opioid-free treatment pathway is both safe and effective for bariatric surgery patients. The alternative method, which combines three different medicines, significantly reduces the need for opioids during treatment.
A randomized controlled trial examines the association between treatment expectancies and the relative efficacy of psilocybin versus escitalopram for major depressive disorder. The results suggest that psilocybin is more effective than escitalopram in treating depression.
A CU Anschutz study found that using a decision aid led to less personal uncertainty and distress among older adults, but not reduced depression. The online tool helped participants feel more confident in their decisions.
A large-scale clinical trial involving over 9,000 patients reveals that text message reminders failed to improve medication refill adherence over a year. The study included diverse representation from subgroups, including females, Hispanic ethnicity, and Spanish-speaking patients.
A systematic review of 18 randomized controlled trials found that drinking enough water can help with weight loss and prevent kidney stones. Drinking eight cups a day significantly decreased the likelihood of getting another kidney stone, while six cups a day helped adults lose weight.
A large-scale clinical trial found that intravenous infusion of exenatide during heart surgeries involving bypass did not significantly reduce the risk of death, stroke, or organ failure. The study included approximately 1,400 adults and a randomized, double-blind, placebo-controlled design.
A randomized trial found reconditioned pacemakers comparable to new devices in terms of safety and effectiveness up to 90 days after implantation. However, longer-term follow-up is necessary to confirm the safety and efficacy of reconditioned devices.
A randomized clinical trial shows cognitive behavioral therapy for prolonged grief outperforms present-centered therapy in treating comorbid symptoms, while both treatments demonstrate effectiveness and acceptability. The findings suggest potential for dissemination and increased patient choice.
A randomized clinical trial found that simultaneous administration of mRNA COVID-19 and inactivated influenza vaccines had comparable reactogenicity to sequential administration. This suggests a safe option for co-administration of these vaccines.
Researchers found that both methods restored blood circulation in about 30% of patients, with no difference in survival or quality of life. The study's results may impact future guidelines for cardiac arrest treatment.
A randomized clinical trial found that montelukast did not shorten the duration of COVID-19 symptoms among outpatients with mild to moderate illness. The study's findings suggest that montelukast is unlikely to be beneficial for treating mild to moderate COVID-19.
A recent study published in eClinicalMedicine found that a combination of amubarvimab and romlusevimab did not reduce the occurrence of long COVID symptoms. The researchers assessed symptom diaries and health-related quality of life questionnaires, but saw no significant difference between treatment and placebo groups.
A nationwide clinical trial found that electronic letter-based nudges significantly increased influenza vaccination in young and middle-aged patients with chronic diseases. The results suggest a scalable, cost-efficient strategy to boost public health.
Patients with acute brain injury who received a liberal transfusion strategy had a lower risk of unfavorable neurological outcomes compared to those on a restrictive strategy. The study found that anemia was a significant predictor of poor outcomes in these patients.
A crossover randomized clinical trial found that using lap or side positions for blood pressure readings leads to substantial overestimation. This misdiagnosis could have serious consequences, particularly for patients with hypertension.
A new study reveals a significant association between COVID-19 and acute kidney disorders, including acute kidney injury, peaking during the second week after infection. Healthcare providers should closely monitor kidney function in COVID-19 patients with moderate to severe cases, particularly during the first few weeks after infection.
A randomized trial halted after patients in the control arm reached a record high two-year progression-free survival rate of 98%. Deintensified treatments involving lower radiation dose and immunotherapy did not perform as well as standard chemoradiation.
A new study found that hypofractionation does not increase complications for patients with breast cancer who undergo mastectomy and plan breast reconstruction. The trial enrolled 898 patients and showed that reducing treatment time by nearly half is safe and effective, saving patients time and money.
A multi-center phase III trial found photon- and proton-based radiation therapies to be similarly safe and effective in treating low- and intermediate-risk prostate cancer. Patients treated with either IMRT or proton therapy reported no significant differences in quality of life, tumor control, or progression-free survival.
A pooled analysis of three large, phase III clinical trials found that more than 40% of brain metastases patients can fully reverse cognitive losses with conformal radiation techniques. Recovery was more likely for those treated with highly targeted radiation compared to standard whole-brain treatment.
Long-term treatment with the nonsteroidal mineralocorticoid receptor antagonist finerenone is estimated to extend event-free survival by up to 3 years among people with heart failure. The FINEARTS-HF randomized clinical trial found this benefit in patients with mildly reduced or preserved ejection fraction.
A study conducted by the University of Gothenburg found that meal boxes with healthy recipes and subsidized meals led to a greater reduction in children's BMI compared to lifestyle treatment alone. The intervention also involved family meals, which were perceived as tolerable and reduced conflicts over food shopping.
A randomized clinical trial found home-based phototherapy to be as effective as office-based treatment for plaque and guttate psoriasis, while reducing patient burden. The study suggests that this approach could become a viable option for everyday clinical practice.
A study suggests that semaglutide may have therapeutic value in preventing opioid overdoses by reducing the associated risk. The results require further validation, but the findings indicate a potential benefit for patients with comorbid type 2 diabetes and opioid use disorder.
A randomized clinical trial found that a voice-activated cognitive behavioral therapy program improved insomnia symptoms in breast cancer survivors. The intervention, delivered in an in-home setting, demonstrated efficacy in reducing sleep disturbances and enhancing overall quality of life.
A randomized clinical trial shows that transitioning insomnia care away from long-term sedatives to cognitive behavioral therapy can be achieved through a mailed, direct-to-patient approach. This method reduces sedative use and improves sleep outcomes in older adults.
A randomized controlled trial found erenumab injections significantly improved medication overuse headache remission rates and reduced acute migraine treatment days in patients with chronic migraine and medication overuse headaches. The study suggests that erenumab can be a simplified treatment option for MOH patients.
The CABINET trial demonstrates that cabozantinib significantly improves median progression-free survival (PFS) for patients with advanced pancreatic and extra-pancreatic neuroendocrine tumors. The treatment also shows promise across all clinical subgroups, including primary tumor site and grade.
Sacubitril/valsartan significantly reduced hospitalization for any reason, particularly in patients with a left ventricular ejection fraction below normal. Lower rates of cardiac and pulmonary hospitalizations were also observed in this patient population.
A study published in The Lancet found that starting medical abortion at home is as safe as in a hospital, with 71% of participants able to be treated as day patients. The procedure also promotes patient autonomy and can reduce healthcare costs.
Researchers at the University of Gothenburg found that hearts stored in a 'heart-in-a-box' method experienced lower rates of heart failure and severe organ failure after transplantation. This breakthrough method uses hypothermic oxygenated machine perfusion to keep the heart oxygenated and functioning better.
A WVU researcher argues that more validation is needed for the increasing number of gallbladder surgeries performed for biliary dyskinesia, a functional gallbladder disorder. The researcher suggests that a combination of factors must come together to diagnose and select patients who would benefit from surgery.
Scalable telehealth mindfulness-based interventions show promise in treating chronic pain by improving function and reducing symptoms. The low-resource approach could accelerate the adoption of nonpharmacological pain treatment in healthcare systems.
Researchers found that when given accurate information about the anti-Mullerian hormone test, women had less interest in taking the test compared to those who viewed misleading online claims. The study highlights the importance of providing evidence-based information to women seeking fertility treatment.
Researchers assessed botulinumtoxin-A treatment to improve walking capacity in children with cerebral palsy. The trial found some evidence of reduced calf pain and delayed improvement in energy cost, but no significant benefit for overall walking ease.
Researchers at IMDEA Software developed FIXCHECK, a method combining static analysis and large language models to generate tests detecting bugs in incorrect patches. The approach was evaluated on 160 patches, yielding 62% effective bug detection results.
A randomized study found that individuals with cash benefits had significantly reduced emergency department visits and hospital admissions. The study suggests that policies addressing poverty through income support may have a positive impact on health and access to care.
A randomized clinical trial found that overground robot-assisted gait training using a wearable robot significantly improved gross motor function and gait pattern in children with cerebral palsy. The study suggests that this type of assistance may complement standard rehabilitation by providing adequate support.
A randomized crossover trial found that a joint-AI model improved clinical diagnosis, but future trials are warranted to confirm its effectiveness. The AI model demonstrated positive human-AI interaction, suggesting its potential to facilitate accurate diagnoses.
Researchers discuss HER2 in breast cancer, highlighting the prognostic and predictive factors. They found an independent positive prognostic effect of HER2-low compared to HER2-zero in early breast cancer, challenging the long-held view that HER2-negative tumors do not benefit from trastuzumab-based therapy.
The study found that massage therapy has moderate-certainty evidence for some conditions but rare conclusive evidence of its superiority over other treatments. The review highlights the need for more research in this area.
A short-term reduction in leisure-time screen media use within families was found to positively affect psychological symptoms of children and adolescents. This effect was particularly notable in mitigating internalizing behavioral issues and enhancing prosocial behavior.
A new study published in The Lancet found that a self-guided smartphone-based behavioral therapy led to significant improvements for patients with fibromyalgia. Stanza, a smartphone app delivering acceptance and commitment therapy, showed improved symptoms including pain intensity, fatigue, and depression.
A web-based cognitive behavioral self-help intervention effectively decreases eating disorder symptoms in individuals with bulimia nervosa, reducing illness-related burden. The digital intervention has potential as a complement to established treatments for bulimia nervosa.
A randomized controlled trial found that four weeks of outdoor gait training, combined with home exercises, improved running biomechanics and reduced the time feet were in contact with the ground. This technique may help patients improve their stride and reduce pain associated with shin splints.
Researchers explore the feasibility of deep learning models in segmenting lesions on PET/CT images to improve salvage radiation therapy planning for prostate cancer. The study demonstrates promising potential to reduce inter- and intra-observer variations, leading to more accurate treatment outcomes.
A recent review of studies on heart failure patients suggests that reducing salt intake has no clinical benefits and may even be counterproductive. Moderate to strict salt restriction was linked with improved quality of life but not mortality or hospitalization rates among patients with heart failure.
A randomized clinical trial found that combining exercise with glucagon-like peptide-1 receptor agonist (GLP-1RA) treatment was the most effective weight loss strategy while preserving bone health. In contrast, GLP-1RA treatment alone reduced bone mineral density at clinically relevant sites.
The ARMMS-T2D study found that bariatric surgery yields greater long-term improvements in quality-of-life compared to medical management, with sustained weight loss correlating with better health and reduced pain.
A systematic review found that community-dwelling older adults are more likely to use wearable monitoring devices if they receive support from healthcare professionals or peers. The interventions that increased awareness and used collaborative goal-setting tools showed the best results.
A randomized clinical trial found that an intermittent fasting plan consisting of two nonconsecutive fasting days and five days of meal replacement diet improved glycemic outcomes and weight loss in the short term compared to metformin or empagliflozin. The study suggests a promising initial intervention for type 2 diabetes management.
A randomized clinical study found that a lateral episiotomy reduced the risk of obstetric anal sphincter injury (OASI) by 53% in first-time mothers. The procedure also did not increase the risk of other complications, but may lead to wound complications.
A randomized clinical trial found that both electronic cigarettes containing nicotine and varenicline were effective for 6-month smoking cessation. The study results suggest a potential new approach to smoking cessation.
The BLING III trial found a 2% lower 90-day mortality and a 6% higher clinical cure rate for continuous β-lactam antibiotic infusions compared to intermittent infusions in critically ill patients with sepsis. Continuous infusions were also associated with improved patient outcomes.
A new WhatsApp-based program has shown significant improvements in treating depression among older adults in Brazil. The Viva Vida program used simple audio messages and images to provide education on depression and behavioral activation, with a 10-point improvement in symptom reduction between intervention and control groups.
A 15-day course of nirmatrelvir-ritonavir did not demonstrate a significant improvement in select postacute sequelae of SARS-CoV-2 infection symptoms in vaccinated adults with prolonged symptom duration. Further studies are needed to determine the role of antivirals in PASC treatment.
Ivonescimab plus chemotherapy significantly improved progression-free survival (7.1 vs 4.8 months) compared to chemotherapy alone in TKI-treated non-small cell lung cancer patients. This treatment may offer a new option for patients with EGFR variant and limited treatment options.